← back to search

Eli Marie Grindedal

University of Oslo · NO
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include BRCA gene mutations in cancer, Prostate Cancer Treatment and Research, Genetic factors in colorectal cancer, and Prostate Cancer Diagnosis and Treatment.
h-index
24
citations
4,041
works
73
NIH funding
primary concept
Medicine
email

Recent publications

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
Nature Cancer 2026cited by 1position: middledoi
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
Gastroenterology 2025cited by 15position: middledoi
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
EBioMedicine 2024cited by 44position: middledoi
From a genomic risk model to clinical trial implementation in a learning health system: the ProGRESS Study
medRxiv 2024cited by 3position: middledoi
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
The American Journal of Human Genetics 2023cited by 23position: middledoi
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study
British Journal of Cancer 2023cited by 8position: middledoi
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry
medRxiv 2023cited by 2position: middledoi
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
Prostate Cancer and Prostatic Diseases 2022cited by 38position: middledoi
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
The Lancet Oncology 2021cited by 92position: middledoi
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Nature Communications 2021cited by 76position: middledoi
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
Prostate Cancer and Prostatic Diseases 2021cited by 25position: middledoi
Prostate cancer risk stratification improved across multiple ancestries with new polygenic hazard score
medRxiv 2021cited by 2position: middledoi
An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk
Nature Communications 2020cited by 245position: middledoi
Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan
Nature Communications 2020cited by 76position: middledoi
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
Cancers 2020cited by 24position: middledoi
Additional SNPs improve the performance of a polygenic hazard score for prostate cancer
medRxiv 2020cited by 1position: middledoi
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
European Urology 2019cited by 235position: middledoi
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Nature Genetics 2019cited by 24position: middledoi
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
medRxiv 2019cited by 13position: middledoi
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
Nature Communications 2019cited by 6position: middledoi
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Nature Genetics 2018cited by 1,003position: middledoi
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
Nature Communications 2018cited by 114position: middledoi
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Nature Communications 2018cited by 113position: middledoi
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Nature Communications 2018cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Randall E. Brand · Magee-Womens Research Institute1 papers (2025–2025) · 1 papers (2025–2025)José G. Treviño · University of Florida1 papers (2025–2025)Salvatore Paiella · Lithuanian Ornithological Society1 papers (2025–2025)Sonia S. Kupfer · University of Illinois Chicago1 papers (2025–2025)Erkut Borazanci · HonorHealth1 papers (2025–2025) · 1 papers (2025–2025)Rosalie C. Sears · Pediatrics and Genetics1 papers (2025–2025)Walter G. Park · Stanford University1 papers (2025–2025) · 1 papers (2025–2025)Ora Gordon · Providence College1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025)Aimee L. Lucas · University of Sydney1 papers (2025–2025)Diane M. Simeone · NYU Langone’s Laura and Isaac Perlmutter Cancer Center1 papers (2025–2025)George Zogopoulos · McGill University Health Centre1 papers (2025–2025)Jessica N. Everett · UC San Diego Health System1 papers (2025–2025)Fay Kastrinos · Columbia University Irving Medical Center1 papers (2025–2025)Bryson W. Katona · Penn Center for AIDS Research1 papers (2025–2025)